1. Home
  2. KYMR vs SXT Comparison

KYMR vs SXT Comparison

Compare KYMR & SXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • SXT
  • Stock Information
  • Founded
  • KYMR 2015
  • SXT 1882
  • Country
  • KYMR United States
  • SXT United States
  • Employees
  • KYMR N/A
  • SXT N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • SXT Major Chemicals
  • Sector
  • KYMR Health Care
  • SXT Industrials
  • Exchange
  • KYMR Nasdaq
  • SXT Nasdaq
  • Market Cap
  • KYMR 4.7B
  • SXT 4.0B
  • IPO Year
  • KYMR 2020
  • SXT N/A
  • Fundamental
  • Price
  • KYMR $67.94
  • SXT $98.83
  • Analyst Decision
  • KYMR Strong Buy
  • SXT Buy
  • Analyst Count
  • KYMR 19
  • SXT 2
  • Target Price
  • KYMR $68.95
  • SXT $110.00
  • AVG Volume (30 Days)
  • KYMR 696.1K
  • SXT 410.3K
  • Earning Date
  • KYMR 11-04-2025
  • SXT 10-31-2025
  • Dividend Yield
  • KYMR N/A
  • SXT 1.69%
  • EPS Growth
  • KYMR N/A
  • SXT 56.32
  • EPS
  • KYMR N/A
  • SXT 3.27
  • Revenue
  • KYMR $43,735,000.00
  • SXT $1,595,084,000.00
  • Revenue This Year
  • KYMR $60.88
  • SXT $4.42
  • Revenue Next Year
  • KYMR N/A
  • SXT $5.78
  • P/E Ratio
  • KYMR N/A
  • SXT $29.72
  • Revenue Growth
  • KYMR N/A
  • SXT 4.25
  • 52 Week Low
  • KYMR $19.45
  • SXT $66.15
  • 52 Week High
  • KYMR $68.80
  • SXT $121.54
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 68.81
  • SXT 61.44
  • Support Level
  • KYMR $63.86
  • SXT $92.41
  • Resistance Level
  • KYMR $68.80
  • SXT $96.64
  • Average True Range (ATR)
  • KYMR 3.52
  • SXT 2.10
  • MACD
  • KYMR 0.19
  • SXT 0.71
  • Stochastic Oscillator
  • KYMR 94.07
  • SXT 96.21

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

Share on Social Networks: